EVALUATION OF SAMPLE PROCESSING ON THE FAMILY OF UNICEL® DXC INTEGRATED SYSTEMS FROM BECKMAN COULTER.
D. Tennyson1, A. Cruz1, M. Cheung1, V. Chin1, J. Zakowski1, F. Tegelaers2, M. Ridder2 and D. Verduin2
SIX SIGMA PERFORMANCE OF THE BECKMAN COULTER DXC 880i, DXC 600 AND ACCESS TECHNOLOGY: EVALUATION OF 62 BLOOD PARAMETERS AND COMPARISON WITH OTHER INSTRUMENTS
M. Balerna, A. Dellamora, R. Francesconi, F. Keller, N. Dueri, B. Guggiari, M. Niosi, P. Jelmini, M. Imperiali.
CONSOLIDATION AND DISCRETE AUTOMATION OF A UNIVERSITY HOSPITAL LABORATORY WITH UNICEL DXC 880i AND AUTOMATE 800
H. Stiegler
LABORATORY CONSOLIDATION WITH THE INTEGRATED SYSTEM UNICEL DXC 880i
A. M. Schweiger, F. S. Keck
HIGH AUTOMATED CORELAB CREATION: NOVI LIGURE LABORATORY ANALYSIS EXPERIENCE
Camogliano L., Ginestri M.
LABORATORY ORGANIZATION: AUTOMATED PRE-ANALYTICAL PHASE CONTRIBUTION TO SAMPLE ANALYSIS PROCESS
Bonelli P., Rossi R., Bonilauri E, Marino M.T.
PRATO’S PRESIDIO OSPEDALIERO MISERICORDIA E DOLCE: LABORATORY ANALYSIS REORGANIZATION EXPERIENCE
Casprini P.,Rispoli M., Ruggeri A.
CONSOLIDATION OF A CORE LABORATORY WITH UNICEL DXC 880i
K. Zahreddine
AUTOMATION OF THE PRE-ANALYTICAL PHASE IN AN ACADEMIC CENTRAL LABORATORY: OUR EXPERIENCE
C. Fillée
IMMUNOTURBIDIMETRIC ASSAY OF SERUM ALBUMIN ON SYNCHRON® SYSTEMS
P. Desvignes, G. Balendet, A. Boutib
SERADYN QMS AMIKACIN MEASURMENT ON BECKMAN COULTER UNICEL DXC 800i
K. Zahreddine
EVALUATION OF LZI BUPRENORPHINE MEASUREMENT IN URINE ON UNICEL DXC 880i
W. Haase1, H. Stiegler2 and H. Lestin3
GENTIAN CYSTATIN C MEASUREMENT ON SYNCHRON UNICEL DXC 800 FOR ROUTINE TESTING OF RENAL DISEASE
J. H. Prinsen
AN ANALYSIS COMPARING DIRECT LDL ASSAY WITH FRIEDEWALD CALCULATION
Casprini P., Camiciottoli M.S., Celli A., Ruggeri A.
ß2-MICROGLOBULIN DETECTION: DIFFERENT ASSAYS WITH DIFFERENT NORMAL RANGES. THE IMPACT ON MULTIPLE MYELOMA PROGNOSTIC STAGING SYSTEM
H. Dürk1, A. Rietschel-Klein1, G. Walther-Wenke2, T. Brinkmann3
IMPACT OF IDMS STANDARDIZATION ON BECKMAN COULTER JAFFÉ METHODS
C. Fillée1, M. Philippe1, J.M. Allaeys1, A. Courbe2, J.L. Ruelle2, M. Othmane3, R. Peeters3 and G. Vranken3.
TRUENESS VERIFICATION OF BECKMAN COULTER’S RECALIBRATED MODULE JAFFE METHOD
C. Fillée1, M. Philippe1, J.M. Allaeys1, M. Othmane2, R. Peeters2 and G. Vranken2.
IMPACT OF PREANALYTICAL FACTORS ON PLASMA SAMPLE FOR HIGH SENSITIVITY TROPONIN I TEST WITH UNICEL DXI 800 ANALYZER
S. Fradin1, S.Goin1, J.P.Vigier2, L.Alliot3, P.Jauzac1
ANTI-MÜLLERIAN-HORMONE: A NEW OVARIAN GROWTH FACTOR OF EMERGING CLINICAL SIGNIFICANCE
T. Katzorke
EVALUATION OF AGE-RELATED REFERENCE-RANGES FOR ANTI-MULLERIAN HORMONE (AMH) IN HEALTHY WOMEN
S. Pfeiffer, M. Scholtes
USING TOTAL OR FREE Β HUMAN CHORIONIC GONADOTROPHIN (HCG) IN SECOND TRIMESTER SCREENING – DOES IT MAKE A DIFFERENCE TO PERFORMANCE ?
S. Turner¹, K.Donalson¹, D.Wright², A. Baker²
SERUM CONCENTRATION OF IL-6, HSCRP, TRANSFERIN AND HAPTOGLOBIN BEFORE AND AFTER A SIX WEEK CYCLE TRAINING IN ELITE YOUNG WATER POLO PLAYERS
V. Dopsaj1,2, J. Martinovic2, I. Obradovic1, M. Dopsaj3
HOW GOOD IS INHIBIN A AS THE FOURTH MARKER ? - A RETROSPECTIVE COMPARISON OF MATERNAL SERUM SCREENING TRIPLE AND QUAD TESTS IN THE SECOND TRIMESTER.
K.Donalson¹, S. Turner¹, D.Wright², A. Baker²
DETERMINATION OF INHIBIN A IN POLYCYSTIC OVARY SYNDROME AND ENDOMETRIOSIS
C. Cosma, L. Penello, F. Favaro, A. Tasinato, D. Faggian, M. Plebani
EFFECTIVENESS AND CLINICAL VALUE OF THE INTEGRATION OF THE INTRA-OPERATIVE INTACT PTH (IO-PTH) ASSAY WITH THE UNICEL® DXI 800 IN AN AUTOMATATED CORE LABORATORY
C. Fillée, M. Mourad and J.M. Ketelslegers
CoMPARISON OF THE CLINICAL PERFORMANCES OF THREE FREE T4 (FT4) AND FREE T3 (FT3) ASSAYS: UNICEL® DXI 800, ARCHITECT® AND ELECSYS® IN A HOSPITAL SETTING
C. Fillée, J. Cumps and J.M. Ketelslegers
ADULTS REFERENCE INTERVALS FOR FREE THYROXINE, FREE TRIIODOTHYRONINE AND THYROTROPIN FOR MEAUX HOSPITAL USING THE ACCESS 2 IMMUNOASSAY SYSTEM
Plouvier, E.1; Medeau, V.2; Alliot, L.3; Kowalski, C.3; Thuillier, F.1; Bigorie, B.2
MONITORING CANCER PATIENTS: CLINICAL PERFORMANCE OF THE ACCESS® BR MONITOR (CA 15-3 ANTIGEN), GI MONITOR (CA 19-9 ANTIGEN) AND OV MONITOR (CA 125 ANTIGEN) ASSAYS ON THE UNICEL® DXI 800 IMMUNOASSAY SYSTEM FROM BECKMAN COULTER: A EUROPEAN MULTICENTER STUDY
P. Stieber1, R. Molina2, M. Gion3, A. Gressner4, F. Troalen5, J. M. Auge2, S. Holdenrieder1, M. Zancan3, M. Wycislo4, D. Nage1, and J.-S. Blanchet6
THE (-2)PROPSA/FPSA RATIO (%(-2)PROPSA)) IMPROVES DIAGNOSTIC ACCURACY IN PROSTATE CANCER DETECTION
R.H.N. van Schaik1, F. H. Jansen2, J. Kurstjens1, W. Horninger3, H. Klocker3, J. Bektic3, M. F. Wildhagen2, M. Roobol2, C. H. Bangma2, G. Bartsch3
20-25% LOWER PSA VALUES WITH PSA TEST STANDARDIZATION TO THE WHO REFERENCE MATERIAL – SUMMARY OF 4 STUDIES IN 1100 PATIENTS
C. Stephan,1 C. Bangma,2 M. Lein,1,3 K. Jung,1,3 G. Vignati,4 M. Philippe,5 A. Semjonow,6 and W. J. Catalona,7
THE NEW AUTOMATED BPHA (BPSA) ASSAY IMPROVES DETECTION OF PROSTATE CANCER IN AN ARTIFICIAL NEURAL NETWORK
C. Stephan1 , H. Cammann2, S. Deger1, M. Schrader1, M. Lein1, K. Jung1, and K. Miller1
An AUTOMATED ASSAY FOR -2PROPSA SIGNIFICANTLY IMPROVES PROSTATE CANCER (PCA) DETECTION IN ARTIFICIAL NEURAL NETWORK OR LOGISTIC REGRESSION MODELS AND ENHANCES DIFFERENTIATION OF AGGRESSIVE PCA
C. Stephan1, A.-M. Kahrs1, H. Cammann2, S. Deger1, M. Schrader1, M. Lein1, K. Jung1, and K. Miller1
STABILITY OF [-2]PROPSA, AN ISOFORM OF FREE PSA, IN BLOOD AND SERUM
A. Semjonow1, T. Köpke1, E. Eltze1, B. Pepping-Schefers1, H. Bürgel1 and C. Darte2.
ANALYTICAL PERFORMANCE OF THE NEW ACCESS® CMV IGG ASSAY
N. Groleau, B. Roussel, V. Potelle, M. Bullenger, J. Poropane, R. Falcou-Briatte, F. Bouniort, R. Theis, O. Flecheux
COMPARATIVE STUDIES OF THE ACCESS® CMV IGG ASSAY
N. Groleau1, B. Roussel1, V. Potelle1, M. Bullenger1, J. Poropane1, R. Falcou-Briatte1, F. Bouniort2, R. Theis3, O. Flecheux1
MULTI-CENTER EVALUATION OF THE CMV IGG ASSAY ON THE FAMILY OF ACCESS® IMMUNOASSAY SYSTEMS FROM BECKMAN COULTER
L. Grangeot-Keros1, N. Gaidot1, M. Rawlins2, O. Flecheux3, J. C. Ritchie4, C. Darte5, F. Bouniort 6, M. D. Olson7
COMPARATIVE STUDY OF THE NEW ACCESS® HBS ANTIBODY ASSAY
C. Chandelier1, A. Pouzet1, M. C. Dickx1, C. Bonchamp1, J. Bonamy1, V. Lemesre1, R. Falcou-Briatte1, F. Bouniort2, S. Taskar3, O. Flecheux1
ANALYTICAL PERFORMANCE OF THE NEW ACCESS® HBS ANTIBODY ASSAY
C. Chandelier1, A. Pouzet1, M.-C. Dickx1, C. Bonchamp1, J. Bonamy1, V. Lemesre1, R. Falcou-Briatte1, F. Bouniort2, S. Taskar3, O. Flecheux1
ANALYTICAL PERFORMANCES OF THE NEW ACCESS® TOXO IGG ASSAY
O. Flecheux1, A. Clement1, C. Stoia1, F. Margotteau1, D. Duhamel1, J. Poropane1, R. Falcou1, F.Bouniort2, C. Walton3
MULTI-CENTER EVALUATION OF THE TOXO IGG ASSAY ON THE FAMILY OF ACCESS® IMMUNOASSAY SYSTEMS FROM BECKMAN COULTER
P. Flori1, D. L. Uettwiller-Geiger2, R. Tran Manh Sung1, C. Darte3, F. Bouniort4, M.D. Olson5
HIGH SENSITIVITY NEW PARAMETERS FOR THE DETECTION OF VITAMIN B12 AND FOLATE DEFICIENCIES
Simon-Lopez, R.1, Sukhacheva, E.2, Tsvetaeva, N.3, Egorova, M.3, Kolenkin, S.4, Achildieva, T.2
NEW BECKMAN COULTER LHD% (LOW HAEMOGLOBIN DENSITY) IN THE ASSESSMENT OF IRON STATUS
Urréchaga E., Ajuria I, Bereciartua E. and Izcara C.
SIDE SCATTER LEVEL OF MAIN POPULATIONS IN PERIPHERAL BLOOD USING FLOW CYTOMETRY AS A TOOL FOR THE SCREENING/DETECTION OF DYSPLASIA AND ITS UTILITY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROMES
Simon-Lopez, R.1, Rusanova, K.2
COULTER LH 750: CLINICAL USEFULNESS OF NEUTROPHIL VCS CELL POPULATION DATA IN THE DIAGNOSIS OF SEPSIS IN NEONATES - CORRELATION WITH ITR
Grimaldi, E.1; Scopacasa F.1, Raimondi, F.2; Di Gaetano, N.3; D’Apice, L.3; Simon-Lopez R.4
USE OF RETICULOCYTE CELLULAR INDICES IN THE DIAGNOSIS OF IRON DEFICIENCY IN AQUATIC ATHLETES
V. Dopsaj1,2, J. Martinovic2, A. Radovic 1, K. Vuksanovic1, M. Dopsaj3
NEW BECKMAN COULTER RSF (RED BLOOD CELL SIZE FACTOR) IN THE ASSESSMENT OF IRON RESTRICTED ERYTHROPOIESIS
Urréchaga E., Ajuria I, Bereciartua E. and Izcara C.
CONCOMITANT IMPLEMENTATION AND USE OF A REMISOL NETWORK IN 5 SWISS HOSPITALS
M. Imperiali, R. Della Bruna, G. Medici, M. Balerna
FIRST PRECISE TURNAROUND TIME (TAT) MEASUREMENT OF LABORATORY PROCESSES USING RADIOFREQUENCY IDENTIFICATION (RFID) TECHNOLOGY
H. Mayer , J. Brümmer
STATISTICAL TEST FOR EQUIVALENCE AND NON INFERIORITY IN ANALYSIS OF METHOD VALIDATION AND COMPARISON EXPERIMENTS. APPLICATION IN ASSESSMENT OF CARRY-OVER
T. Keller, T. Brinkmann